Mackenzie Financial Corp Senseonics Holdings, Inc. Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.34 $3,168 - $4,422	3,300 Added 15.45%	24,657 $25,000
Q2 2022 Aug 10, 2022	BUY	$0.94 - $1.94 $5,796 - $11,963	6,167 Added 40.6%	21,357 $22,000
Q1 2022 May 13, 2022	BUY	$1.54 - $3.71 $2,188 - $5,271	1,421 Added 10.32%	15,190 $30,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $27,613 - $41,848	-10,703 Reduced 43.74%	13,769 $37,000
Q3 2021 Nov 08, 2021	BUY	$2.77 - $4.05 $28,694 - $41,953	10,359 Added 73.4%	24,472 $83,000
Q2 2021 Aug 11, 2021	BUY	$1.71 - $4.14 $24,133 - $58,427	14,113 New	14,113 $54,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.